Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zynerba Pharma CS
(NQ:
ZYNE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zynerba Pharma CS
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week?
September 06, 2021
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Marijuana Drug Stocks: All You Need To Know Is Here!
August 13, 2021
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Which Psychedelic Drug Stock Category Outperformed Last Week
August 10, 2021
Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Is Cannabis The Hottest Market Right Now? Aurora, Canopy And Sundial Among Top Bullish Stocks For August 5, 2021
August 05, 2021
GAINERS: 22nd Century Group (AMEX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD-Infused Products Market Is Expected To Exceed $210 Billion By 2028, At A CAGR Of 45.6%
August 05, 2021
Via
FinancialNewsMedia
Intec Pharma, GreenTree & MedMen Among Top Cannabis Stock Movers On July 29, 2021
July 29, 2021
GAINERS: Intec Pharma (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison
July 24, 2021
We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
AusCann, Flower One, Item 9 Labs & MariMed Among Top Cannabis Stock Movers On July 23, 2021
July 23, 2021
GAINERS: Cann Gr (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Trend Continues In Cannabis Market: Tilray, Canopy Growth & GrowGen Among Top Cannabis Movers For July 21, 2021
July 21, 2021
GAINERS: Flower One Hldgs (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Curaleaf, Ayr Wellness, Gage Cannabis And Three Others Added To Green Market Report Cannabis Company Index After 'Rough Second Quarter' For Weed Stocks
July 19, 2021
The Green Market Report Cannabis Company Index has selected the six companies it plans to add for the third...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Pot And Psychedelic Stock Indices Declined 3.2% Last Week But Remain Up YTD
July 18, 2021
The four pot- and psychedelic-related stock categories that I use to track the performance of the cannabis/psychedelic stock sector were down across the board last week but remain +14.5% YTD.
Via
Talk Markets
How The Pot And Psychedelic Stocks Performed Last Week And YTD
July 13, 2021
Approximately 100 clinical-stage marijuana and mushroom/ketamine psychedelic drug stocks now trade on the various North American stock exchanges.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Rhinomed, Zelira And Alcanna Among Top Cannabis Stock Movers On July 12, 2021
July 12, 2021
GAINERS: Origin Agritech (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
18 Key Biopharma Catalysts To Keep An Eye On In Q3
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the...
Via
Talk Markets
18 Key Biopharma Catalysts To Keep An Eye On In Q3
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...
Via
Benzinga
Pot Stocks Down In June - Remain +29.6% YTD
July 04, 2021
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Tilray, KushCo And Aurora Among Top Cannabis Stock Movers On June 28, 2021
June 28, 2021
GAINERS: Mexco Energy (AMEX:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From June 25, 2021
June 25, 2021
GAINERS: Australis Capital (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From June 11, 2021
June 11, 2021
GAINERS: CURE Pharmaceutical Hldg (O...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Zynerba's Zygel Improves Sleep In Children With Severe Epilepsies
June 11, 2021
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) presents sleep data from an open-label Phase 2 trial evaluating Zygel for developmental & epileptic encephalopathies...
Via
Benzinga
Cannabis Stock Gainers And Losers From June 8, 2021
June 08, 2021
GAINERS: AusCann Group Holdings (OT...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
June 10, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From June 2, 2021
June 02, 2021
GAINERS: Sundial Growers (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From June 1, 2021
June 01, 2021
GAINERS: Hollister Biosciences (OTC...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From May 28, 2021
May 28, 2021
GAINERS: Canada House Wellness (OTC...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From May 26, 2021
May 26, 2021
GAINERS: ReneSola (NYSE:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From May 25, 2021
May 25, 2021
GAINERS: Elixinol Wellness (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From May 20, 2021
May 20, 2021
GAINERS: Claritas Pharmaceuticals (...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From May 18, 2021
May 18, 2021
GAINERS: Cansortium (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
May 14, 2021
In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down. On Monday, Trulieve Cannabis Corp.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.